BridgeMD
New treatment option for Juvenile Idiopathic Arthritis
Official title M3-JIA: Making Mindfulness Matter for Children With JIA
ClinicalTrials.gov ID: NCT06376149
What this study is testing
- What it's testing
- The investigator will evaluate the efficacy of M3©, an intervention for patients with JIA and their caregivers. Children with Juvenile arthritis and their parents will attend an 8 week online program called Making Mindfulness Matter (M3).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Children aged 4 to 12 years diagnosed with JIA
- Children have reasonable comprehension of spoken language and can follow simple instructions
- Children with JIA and their caregivers are willing to attend intervention sessions and have access to technology and internet to attend the online...
- Children with JIA and their caregivers have an adequate understanding of English
You likely can't join if
- Other major co-morbid disorders (e.g. Crohn's disease, diabetes, renal failure).
- Concurrent enrollment in other intervention trials or practicing any complementary health interventions such as yoga, meditation, or daily...
The study team makes the final eligibility decision.
Where it's taking place
- Hamilton, Ontario, Canada
- London, Ontario, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamilton, Ontario, Canada; London, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.